In 2015 CMS started with the $42 typical reimbursement for 20 minutes per month multiple chronic condition (MCC) management (CCM) by phone or video. Doctors reported challenges of the administration (tracking, reporting, false signals and billing) and several years of results for a single biomarker at a time has not yet shown clinical patient health outcomes improvements. The patient and doctors mostly feel the communications is better and some evidence of ER utilization reduction.
Accenture and Fair Health studies have seen around 80% of patients would prefer a virtual services capability. Many health systems and doctor groups lack the full spectrum of engineering, clinical, IT, and business expertise and bandwidth to develop an at home care model that provides more evidence-based approach with support and validation that each patient is achieving improved care engagement and outcomes. Efficiently and automatically in most cases collecting 10 or more biomarkers spanning physical, mental, behavioral, social and quality of life variables daily with patient engagement is a better starting point, then adding multi-health variable P7 Systems Medicine[DN1] decision support to simplify seeing actionable insights changes the game for every 2-week small changes that mean a lot for each patient participating. Prior to COVID-19, health systems had gaps of senior health system leadership commitment to telemedicine (mostly pilot activities and only about 10% doctors had used tele-health) and there were funding gaps, which now are mostly addressed. Over the last few years CMS added RPM with a $57 PPM to cover the technology and additional RPM and CCM complex chronic care and it’s making it so there is anywhere from $200-$450 billing per patient. IndividuALLytics® has built a business model around average of $200 PPM for MCC patients with a fully turnkey approach for devices/technology, support, administration, billing, and multi-disciplinary connect care, so doctors can help 100% of their MCC patients with improved care outcomes faster that also improves FTE productivity and earnings. IndividuALLytics ® N-of-1 individual science, multi-disciplinary software and collaborative program, and on average $1,000 to $2,500 of patient device/technology financing covered by health insurance adds high value compared to group average science, mono-therapies, basic nurse/medical assistant tele-care, and multi-year device/technology financing. IndividuALLytics® Supports The Best Care for 100% of Patients and Providers.
IndividuALLytics® N-of-1 individual science, multi-disciplinary software and collaborative program, and on average $1,000 of patient device/technology financing covered by health insurance adds high value compared to group average science, mono-therapies, basic nurse/MA tele-care, and on average $300 of patient device/technology financing. IndividuALLytics® Supports The Best Care for 100% of Patients and Providers.
Ready to learn more?
If you are interested in working with IndividuALLytics® to improve your patients’ health and quality of life and increase your earnings and savings while saving you time, we can schedule a short presentation to share more information and answer any questions.
Our software and collaborative care program will provide a more personal, convenient, and successful healthcare experience. Click below to get in touch with us.